Cited by 128Healthcare Policy and ManagementEconomic and Financial Impacts of CancerHealthcare cost, quality, practices

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Changing Physician Incentives for Affordable, Quality Cancer Care: Results of an Episode Payment Model

Newcomer, Lee N., Gould, Bruce, Page, Ray D., Donelan, Sheila A., Perkins, Monica·2014·Journal of Oncology Practice

DOI 10.1200/jop.2014.001488

Open this paper in CoChat — free account

Abstract

Modifying the current fee-for-service payment system for cancer therapy with feedback data and financial incentives that reward outcomes and cost efficiency resulted in a significant total cost reduction. Eliminating existing financial chemotherapy drug incentives paradoxically increased the use of chemotherapy.

Integrity signals

Registry

Crossref · 10.1200/jop.2014.001488

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

How Medicare’s Payment Cuts For Cancer Chemotherapy Drugs Changed Patterns Of Treatment
Jacobson, M., Earle, C. C., Price, M., & Newhouse, J. P. (2010) · Health Affairs · doi:10.1377/hlthaff.2009.0563 · Cited by 171
Episode-Based Payment For Cancer Care: A Proposed Pilot For Medicare
Bach, P. B., Mirkin, J. N., & Luke, J. J. (2011) · Health Affairs · doi:10.1377/hlthaff.2010.0752 · Cited by 57
Who Will Have Health Insurance in the Future? An Updated Projection
Young, R. A., & DeVoe, J. E. (2012) · The Annals of Family Medicine · doi:10.1370/afm.1348 · Cited by 56
Changing Physician Incentives For Cancer Care To Reward Better Patient Outcomes Instead Of Use Of More Costly Drugs
Newcomer, L. N. (2012) · Health Affairs · doi:10.1377/hlthaff.2012.0002 · Cited by 54
Self-citation

Show all 4 references

Sorted by citations

Association Between Hospital Participation in a Medicare Bundled Payment Initiative and Payments and Quality Outcomes for Lower Extremity Joint Replacement Episodes
Dummit, L. A., Kahvecioglu, D. C., Marrufo, G. M., Rajkumar, R., Marshall, J., Tan, E., Press, M. J., Flood, S. M., Muldoon, L., Gu, Q., et al. (2016) · JAMA · doi:10.1001/jama.2016.12717 · Cited by 350
Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer
Narang, A. K., & Nicholas, L. H. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.4865 · Cited by 221
Value and affordability of CAR T-cell therapy in the United States
Fiorenza, S., Ritchie, D. S., Ramsey, S. D., Turtle, C. J., & Roth, J. A. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-0956-8 · Cited by 152
Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage
Pfister, D. G., Rubin, D. M., Elkin, E. B., Neill, U. S., Duck, E., Radzyner, M. H., & Bach, P. B. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3151 · Cited by 147
The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology
American Society of Clinical Oncology (2016) · Journal of Oncology Practice · doi:10.1200/jop.2015.010462 · Cited by 136
Minimizing the burden of cancer in the United States: Goals for a high‐performing health care system
Yabroff, K. R., Gansler, T. S., Wender, R. C., Cullen, K. J., & Brawley, O. W. (2019) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21556 · Cited by 113
Centers for Medicare and Medicaid Services: Using an Episode-Based Payment Model to Improve Oncology Care
Kline, R. M., Bazell, C., Smith, E., Schumacher, H., Rajkumar, R., & Conway, P. H. (2015) · Journal of Oncology Practice · doi:10.1200/jop.2014.002337 · Cited by 110
Characterizing Potentially Preventable Cancer- and Chronic Disease–Related Emergency Department Use in the Year After Treatment Initiation: A Regional Study
Panattoni, L. E., Fedorenko, C. R., Greenwood-Hickman, M. A., Kreizenbeck, K. L., Walker, J. R., Martins, R. G., Eaton, K. D., Rieke, J. W., Conklin, T., Smith, B. R., et al. (2018) · Journal of Oncology Practice · doi:10.1200/jop.2017.028191 · Cited by 105
The State of Cancer Care in America, 2015: A Report by the American Society of Clinical Oncology
American Society of Clinical Oncology (2015) · Journal of Oncology Practice · doi:10.1200/jop.2015.003772 · Cited by 103
Opportunities and Challenges in Leveraging Electronic Health Record Data in Oncology
Berger, M. L., Curtis, M. D., Smith, G., Harnett, J., & Abernethy, A. P. (2016) · Future Oncology · doi:10.2217/fon-2015-0043 · Cited by 98
Improving outcomes and mitigating costs associated with CAR T-cell therapy
Rebecca Borgert, P. (2021) · The American Journal of Managed Care · doi:10.37765/ajmc.2021.88737 · Cited by 87
Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes
Keating, N. L., Jhatakia, S., Brooks, G. A., Tripp, A. S., Cintina, I., Landrum, M. B., Zheng, Q., Christian, T. J., Glass, R. J., Hsu, V. D., et al. (2021) · JAMA · doi:10.1001/jama.2021.17642 · Cited by 76
Immune-Based Cancer Treatment: Addressing Disparities in Access and Outcomes
Osarogiagbon, R. U., Sineshaw, H. M., Unger, J. M., Acuña-Villaorduña, A., & Goel, S. (2021) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_323523 · Cited by 80
Alternative payment and care‐delivery models in oncology: A systematic review
Aviki, E. M., Schleicher, S. M., Mullangi, S., Matsoukas, K., & Korenstein, D. (2018) · Cancer · doi:10.1002/cncr.31367 · Cited by 60
Second‐opinion interpretations of neuroimaging studies by oncologic neuroradiologists can help reduce errors in cancer care
Hatzoglou, V., Omuro, A. M. P., Haque, S. S., Khakoo, Y., Ganly, I., Oh, J. H., Shukla‐Dave, A., Fatovic, R., Gaal, J., & Holodny, A. I. (2016) · Cancer · doi:10.1002/cncr.30083 · Cited by 54
Translating economic evaluations into financing strategies for implementing evidence-based practices
Dopp, A. R., Kerns, S. E. U., Panattoni, L., Ringel, J. S., Eisenberg, D., Powell, B. J., Low, R., & Raghavan, R. (2021) · Implementation Science · doi:10.1186/s13012-021-01137-9 · Cited by 52
Effects of Monetary Incentives in Physician Groups: A Systematic Review of Reviews
Heider, A.-K., & Mang, H. (2020) · Applied Health Economics and Health Policy · doi:10.1007/s40258-020-00572-x · Cited by 56
Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer
Reyes, C., Engel-Nitz, N. M., Byfield, S. D., Ravelo, A., Ogale, S. S., Bancroft, T., Anderson, A. J., Chen, M. W., & Matasar, M. J. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0018 · Cited by 41
Association of a Bundled-Payment Program With Cost and Outcomes in Full-Cycle Breast Cancer Care
Wang, C.-H. J., Cheng, S. H., Wu, J.-Y., Lin, Y.-P., Kao, W.-H., Lin, C.-L., Chen, Y.-J., Tsai, S., Kao, F., & Huang, A. T. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.4549 · Cited by 38
The Affordable Care Act and Cancer Care Delivery
Brooks, G. A., Hoverman, J. R., & Colla, C. H. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000259 · Cited by 38
Voluntary Regulation: Evidence from Medicare Payment Reform
Liran Einav, B., Finkelstein, A. N., Ji, Y., & Mahoney, N. (2021) · The Quarterly Journal of Economics · doi:10.1093/qje/qjab035 · Cited by 38
Health care resource utilization and costs during episodes of care for type 2 diabetes mellitus-related comorbidities
Candrilli, S. D., Meyers, J., Boye, K. S., & Bae, J. P. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.009 · Cited by 35
Oncology Care Model: Short- and Long-Term Considerations in the Context of Broader Payment Reform
Clough, J. D., & Kamal, A. H. (2015) · Journal of Oncology Practice · doi:10.1200/jop.2015.005777 · Cited by 33
Improving Price Transparency in Cancer Care
Henrikson, N. B., & Shankaran, V. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2015.006171 · Cited by 33
Patient-Centered Medical Homes in Community Oncology Practices: Changes in Spending and Care Quality Associated With the COME HOME Experience
Waters, T. M., Kaplan, C. M., Graetz, I., Price, M. M., Stevens, L. A., & McAneny, B. L. (2018) · Journal of Oncology Practice · doi:10.1200/jop.18.00479 · Cited by 32
The Economics of Colon Cancer
Orangio, G. R. (2017) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.11.007 · Cited by 31
Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope Experience
Bosserman, L. D., Cianfrocca, M. E., Yuh, B. E., Yeon, C. H., Chen, H., Sentovich, S. M., Polverini, A. C., Zachariah, F. J., Deaville, D., Lee, A. B., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020188 · Cited by 31
Value-Based Payment Models In The Commercial Insurance Sector: A Systematic Review
Milad, M. A., Murray, R. C., Navathe, A. S., & Ryan, A. M. (2022) · Health Affairs · doi:10.1377/hlthaff.2021.01020 · Cited by 31
Development and Feasibility of Bundled Payments for the Multidisciplinary Treatment of Head and Neck Cancer: A Pilot Program
Spinks, T. E., Guzman, A. B., Beadle, B. M., Lee, S., Jones, D., Walters, R., Incalcaterra, J., Hanna, E. Y., Hessel, A. C., Weber, R. S., et al. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2017.027029 · Cited by 30
Self-citation
The Radiation Oncology Job Market: The Economics and Policy of Workforce Regulation
Falit, B. P., Pan, H. Y., Smith, B. D., Alexander, B. M., & Zietman, A. L. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.05.029 · Cited by 29
Why is appropriate healthcare inaccessible for many European breast cancer patients? – The EBCC 12 manifesto
Cardoso, F., MacNeill, F. A., Penault-Llorca, F. M., Eniu, A. E., Sardanelli, F., Nordström, E. B., & Poortmans, P. M. (2021) · The Breast · doi:10.1016/j.breast.2020.12.010 · Cited by 29
Wide Variation In Payments For Medicare Beneficiary Oncology Services Suggests Room For Practice-Level Improvement
Clough, J. D., Patel, K., Riley, G. F., Rajkumar, R., Conway, P. H., & Bach, P. B. (2015) · Health Affairs · doi:10.1377/hlthaff.2014.0964 · Cited by 27
The Patient-Centered Medical Home in Oncology: From Concept to Reality
Page, R. D., Newcomer, L. N., Sprandio, J. D., & McAneny, B. L. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.e82 · Cited by 26
Self-citation
Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death
Chen, C. T., Li, L., Brooks, G. A., Hassett, M. J., & Schrag, D. (2017) · Health Services Research · doi:10.1111/1475-6773.12745 · Cited by 26
Reducing Cancer Costs Through Symptom Management and Triage Pathways
Barkley, R., Soobader, M.-J., Wang, J., Blau, S., & Page, R. D. (2019) · Journal of Oncology Practice · doi:10.1200/jop.18.00082 · Cited by 25
Self-citation
Transforming Prior Authorization to Decision Support
Newcomer, L. N., Weininger, R. B., & Carlson, R. W. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2016.015198 · Cited by 25
Self-citation
Diffusion of Bevacizumab Across Oncology Practices
Keating, N. L., Huskamp, H. A., Schrag, D., McWilliams, J. M., McNeil, B. J., Landon, B. E., Chernew, M. E., & Normand, S. T. (2017) · Medical Care · doi:10.1097/mlr.0000000000000840 · Cited by 24
Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective
Sagar, B. T. A., Yu, L., & Castel, L. D. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1339353 · Cited by 23
Direct medical costs of treatment in newly-diagnosed high-grade glioma among commercially insured US patients
Jiang, S., Hill, K., Patel, D. A., Waldeck, A. R., Botteman, M. F., Aly, A., & Norden, A. D. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1364258 · Cited by 22
Redesigning Advanced Cancer Care Delivery: Three Ways to Create Higher Value Cancer Care
Patel, M. I., Moore, D., & Milstein, A. S. (2015) · Journal of Oncology Practice · doi:10.1200/jop.2014.001065 · Cited by 21
Quality of care at safety‐net hospitals and the impact on pay‐for‐performance reimbursement
Sarkar, R. R., Courtney, P. T., Bachand, K., Sheridan, P. E., Riviere, P. J., Guss, Z. D., Lopez, C. R., Brandel, M. G., Banegas, M. P., & Murphy, J. D. (2020) · Cancer · doi:10.1002/cncr.33137 · Cited by 21
Three-Year Results of a Medicare Advantage Cancer Management Program
Hoverman, J. R., Neubauer, M., Jameson, M., Hayes, J. E., Eagye, K. J., Abdullahpour, M., Haydon, W., Sipala, M., Supraner, A., Kolodziej, M. A., et al. (2018) · Journal of Oncology Practice · doi:10.1200/jop.17.00091 · Cited by 20
Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma
Reyes, C. M., Engel-Nitz, N. M., Byfield, S. D., Ravelo, A., Ogale, S. S., Bancroft, T., Anderson, A. J., Chen, M. W., & Matasar, M. J. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0019 · Cited by 19
Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy
Mahendraratnam, N., Farley, J. F., Basch, E., Proctor, A., Wheeler, S. B., & Dusetzina, S. B. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04730-3 · Cited by 18
A New Approach to Cancer Bundled Payments in Medicare—The Enhancing Oncology Model
Kocher, R. P., & Adashi, E. Y. (2023) · JAMA Health Forum · doi:10.1001/jamahealthforum.2022.4904 · Cited by 18
A Pathway Through the Bundle Jungle
Polite, B. N., Ward, J. C., Cox, J. V., Morton, R. F., Hennessy, J. E., Page, R. D., & Conti, R. M. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2015.008789 · Cited by 17
Self-citation
Essentials for improving service quality in cancer care
Berry, L. L., & Mate, K. S. (2016) · Healthcare · doi:10.1016/j.hjdsi.2016.01.003 · Cited by 17
No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations
Daly, B., Hantel, A., Wroblewski, K., Balachandran, J. S., Chow, S. L.-M., DeBoer, R. J., Fleming, G. F., Hahn, O. M., Kline, J. P., Liu, H., et al. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2016.012823 · Cited by 17
Value‐Based Physician Payment in Oncology: Public and Private Insurer Initiatives
Robinson, J. C. (2017) · Milbank Quarterly · doi:10.1111/1468-0009.12249 · Cited by 17
The impact of provider payment reforms and associated care delivery models on cost and quality in cancer care: A systematic literature review
Nejati, M., Razavi, M., Harirchi, I., Zendehdel, K., & Nejati, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214382 · Cited by 18
Association Between Spending and Outcomes for Patients With Cancer
Li, M., Lakdawalla, D., & Goldman, D. P. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01451 · Cited by 17
Intentional Approach to Team-Based Oncology Care: Evidence-Based Teamwork to Improve Collaboration and Patient Engagement
Kosty, M. P., Bruinooge, S. S., & Cox, J. V. (2015) · Journal of Oncology Practice · doi:10.1200/jop.2015.005058 · Cited by 17
Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform
Shirvani, S. M., Jiang, J., Likhacheva, A., Hoffman, K. E., Shaitelman, S. F., Caudle, A. S., Buchholz, T. A., Giordano, S. H., & Smith, B. D. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.01.059 · Cited by 15
A Brighter Future? The Impact of Insurance and Socioeconomic Status on Cancer Outcomes in the USA: A Review
Grant, S. R., Walker, G. V., Guadagnolo, B. A., Koshy, M., & Mahmood, U. X. (2016) · Future Oncology · doi:10.2217/fon-2015-0028 · Cited by 15
Association Between a National Insurer’s Pay-for-Performance Program for Oncology and Changes in Prescribing of Evidence-Based Cancer Drugs and Spending
Bekelman, J. E., Gupta, A., Fishman, E., Debono, D. J., Fisch, M. J., Liu, Y., Sylwestrzak, G., Barron, J. O., & Navathe, A. S. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00890 · Cited by 15
Debating the Oncologist's Role in Defining the Value of Cancer Care: Our Duty Is to Our Patients
Sulmasy, D. P., & Moy, B. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.8716 · Cited by 14
Payment Reform: Unprecedented and Evolving Impact on Gynecologic Oncology
Apte, S. M., & Patel, K. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00084 · Cited by 13
Improving Oncology Quality Measurement in Accountable Care: Filling Gaps with Cross-Cutting Measures
Valuck, T., Blaisdell, D., Dugan, D. P., Westrich, K. D., Dubois, R. W., Miller, R. S., & McClellan, M. (2017) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2017.23.2.174 · Cited by 11
The Oncology Care Model at 5 Years—Value-Based Payment in the Precision Medicine Era
Mullangi, S., Schleicher, S. M., & Parikh, R. B. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.1512 · Cited by 11
Balancing the CAR T: perspectives on efficacy and safety of CAR T-cell therapy in hematologic malignancies
Buie, L. W. (2021) · The American Journal of Managed Care · doi:10.37765/ajmc.2021.88736 · Cited by 11
Do Case Rates Affect Physicians' Clinical Practice in Radiation Oncology?: An Observational Study
Loy, B. A., Shkedy, C. I., Powell, A. C., Happe, L. E., Royalty, J. A., Miao, M. T., Smith, G. L., Long, J. W., & Gupta, A. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149449 · Cited by 11
An ED pilot intervention to facilitate outpatient acute care for cancer patients
Brooks, G. A., Chen, E. J., Murakami, M. A., Giannakis, M., Baugh, C. W., & Schrag, D. (2016) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2016.06.076 · Cited by 11
The Oncology Care Model: A Critique
Thomas, C. A., & Ward, J. C. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_156883 · Cited by 11
Payment Reform, Medication Use, and Costs: Can We Afford to Leave Out Drugs?
Parekh, N., McClellan, M., & Shrank, W. H. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4794-y · Cited by 10
Clinical Factors Associated With Cost in Head and Neck Cancer: Implications for a Bundled Payment Model
Tom, M. C., Ross, R. B., Koyfman, S. A., Adelstein, D. J., Lorenz, R. R., Burkey, B. B., Shah, C., Suh, J. H., Bolwell, B. J., Savage, C., et al. (2019) · Journal of Oncology Practice · doi:10.1200/jop.18.00665 · Cited by 10
Classifying Stage IV Lung Cancer From Health Care Claims: A Comparison of Multiple Analytic Approaches
Brooks, G. A., Bergquist, S. L., Landrum, M. B., Rose, S., & Keating, N. L. (2019) · JCO Clinical Cancer Informatics · doi:10.1200/cci.18.00156 · Cited by 10
Voluntary Regulation: Evidence from Medicare Payment Reform
Liran Einav, B., Finkelstein, A. N., Ji, Y., & Mahoney, N. (2020) · National Bureau of Economic Research · doi:10.3386/w27223 · Cited by 10
Quality measurement in breast cancer
Edge, S. B. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23760 · Cited by 9
Impact of oncologist payment method on health care outcomes, costs, quality: a rapid review
McPherson, E., Hedden, L., & Regier, D. A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0341-2 · Cited by 9
Value Tools in Managed Care Decision Making: Current Hurdles and Future Opportunities
Schafer, J., Galante, D., & Shafrin, J. T. (2017) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2017.23.6-a.s21 · Cited by 9
Alternative Payment Models in Medical Oncology: Assessing Quality-of-Care Outcomes Under Partial Capitation.
Ems, D., Murty, S., Loy, B. A., Gallagher, J. E., Happe, L. E., Rogstad, T. L., Finnel, D., & Fernandez, J. D. (2018) · Europe PMC (PubMed Central) · Cited by 9
Les modes de paiements à la coordination : État des lieux et pistes pour une application en France
Girault, A., Gervès‐Pinquié, C., & Minvielle, É. (2017) · Journal de gestion et d économie médicales · doi:10.3917/jgem.172.0109 · Cited by 9
Spending On Targeted Therapies Reduced Mortality In Patients With Advanced-Stage Breast Cancer
Li, M., Goldman, D. P., & Chen, A. J. (2021) · Health Affairs · doi:10.1377/hlthaff.2020.01714 · Cited by 8
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans
Bosserman, L. D., Mambetsariev, I., Ladbury, C. J., Barzi, A., Johnson, D., Morse, D., Deaville, D., Smith, W., Rajurkar, S. P., Merla, A., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226738 · Cited by 8
Value-Based Medicine and Integration of Tumor Biology
Brooks, G. A., Bosserman, L. D., Mambetsariev, I., & Salgia, R. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175519 · Cited by 7
Docetaxel chemotherapy in metastatic castration-resistant prostate cancer: cost of care in Medicare and commercial populations
Armstrong, A. J., Bui, C. N., Fitch, K., Sawhney, T. G., Brown, B. A., Flanders, S. C., Balk, M., Deangelis, J., & Chambers, J. D. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1308919 · Cited by 7
Payment for Cancer Care: Time for a New Prescription
Schnipper, L. E., & Meropol, N. J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.9573 · Cited by 7
Oncology Payment Reform to Achieve Real Health Care Reform
McClellan, M., & Thoumi, A. I. (2015) · Journal of Oncology Practice · doi:10.1200/jop.2015.004655 · Cited by 6
Association of Practice-Level Hospital Use With End-of-Life Outcomes, Readmission, and Weekend Hospitalization Among Medicare Beneficiaries With Cancer
Clough, J. D., Strawbridge, L. M., LeBlanc, T. W., Hammill, B. G., & Kamal, A. H. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2016.013102 · Cited by 6
Oncology drug costs—the imaginary crisis?
Turck, R. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw548 · Cited by 6
Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes
Baumgardner, J. R., Shahabi, A., Linthicum, M. T., Vine, S. M., Zacker, C., & Lakdawalla, D. N. (2018) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2018.24.6.504 · Cited by 6
Identifying the Most Costly Patients in Radiation Oncology and Predicting the Top Spenders
Waddle, M. R., Kaleem, T. A., Stross, W. C., Malouff, T. D., White, L. J., Li, Z., Naessens, J. M., Spaulding, A., Aljabri, D., Ma, D. J., et al. (2019) · Journal of Oncology Practice · doi:10.1200/jop.18.00627 · Cited by 5
Role of the 340B Drug Discount Program in Recent Cancer Care Trends
Kantarjian, H. M., & Chapman, R. (2015) · Journal of Oncology Practice · doi:10.1200/jop.2014.002139 · Cited by 5
Outcome measures for oncology alternative payment models: practical considerations and recommendations.
Hlávka, J. P., Lin, P., & Neumann, P. J. (2019) · PubMed · Cited by 5
Value-based payment for oncology services in the United States and France
Robinson, J. C., & Megerlin, F. (2016) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2016.09.001 · Cited by 5
Quality of Care at Safety-Net Hospitals and the Impact on Pay-for-Performance Reimbursement
Sarkar, R. R., Courtney, P. T., Bachand, K., Sheridan, P., Riviere, P., Guss, Z. D., Lopez, C. R., Brandel, M. G., Banegas, M. P., & Murphy, J. D. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.06.218 · Cited by 5
Designing a commercial medical bundle for cancer care: Hawaii Medical Service Association's Cancer Episode Model
Urwin, J. W., Caldarella, K. L., Matloubieh, S. E., Lee, E., Mugiishi, M. M., Kohatsu, L., Yoshimoto, J., Tom, J., Okamura, S., Wang, E., et al. (2020) · Healthcare · doi:10.1016/j.hjdsi.2020.100422 · Cited by 4
Variations in Proton Therapy Coverage in the State of Texas: Defining Medical Necessity for a Safe and Effective Treatment
Thaker, N. G., Agarwal, A., Palmer, M. T., Hontiveros, R. L., Hahn, S. M., Minsky, B. D., Walters, R. S., Bingham, J. W., Feeley, T. W., Buchholz, T. A., et al. (2015) · International Journal of Particle Therapy · doi:10.14338/ijpt-15-00029.1 · Cited by 4
Policy Diffusion across Disparate Disciplines: Private- and Public-Sector Dynamics Affecting State-Level Adoption of the ACA
Conti, R. M., & Jones, D. K. (2016) · Journal of Health Politics Policy and Law · doi:10.1215/03616878-3766771 · Cited by 4
New Mexico Cancer Center and the COME HOME Model: Pathways improving the value of community-based cancer care
Parikh, R. B., Bekelman, J. E., Hodlofksi, A., & Navathe, A. S. (2018) · Healthcare · doi:10.1016/j.hjdsi.2017.11.001 · Cited by 4
Medical oncologists’ willingness to participate in bundled payment programs
Murciano‐Goroff, Y. R., McCarthy, A. M., Bristol, M. N., Domchek, S. M., Groeneveld, P. W., Motanya, U. N., & Armstrong, K. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3202-y · Cited by 4
Rethinking clinical oncology drug research in an era of value‐based cancer care: A role for chemotherapy pathways
Hoverman, J. R. (2020) · Cancer Medicine · doi:10.1002/cam4.3193 · Cited by 3
Quantitative evaluation of radiation oncologists’ adaptability to lower reimbursing treatment programs
Gill, B. S., Beriwal, S., Rajagopalan, M. S., Wang, H., Hodges, K., & Greenberger, J. S. (2014) · Practical Radiation Oncology · doi:10.1016/j.prro.2014.10.014 · Cited by 3
Uncertainty in lung cancer stage for survival estimation via set‐valued classification
Bergquist, S. L., Brooks, G. A., Landrum, M. B., Keating, N. L., & Rose, S. (2022) · Statistics in Medicine · doi:10.1002/sim.9448 · Cited by 3
Commercial Health Plans and the Business of Oncology: Evolution, Cost Pressures, and Policy Responses
Langer, L., & Kolodziej, M. A. (2026) · JCO Oncology Practice · doi:10.1200/op-25-01339 · Cited by 2
The Impact of Health Delivery Integration on Cancer Outcomes
Golla, V., & Kaye, D. R. (2021) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2021.08.003 · Cited by 3
Specialty Payment Model Opportunities and Assessment
Mulcahy, A. W., Chan, C. T., Hirshman, S. D., Huckfeldt, P. J., Kofner, A., Liu, J., Lovejoy, S. L., Popescu, I., Timbie, J. W., & Hussey, P. S. (2015) · Cited by 2
Engaging Patients in Value-Based Cancer Care
Zafar, S. Y., Polite, B. N., & McClellan, M. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2826 · Cited by 2
Use of Optimal Evidence-Based Anticancer Drug Regimens in Physician Offices Versus Hospital Outpatient Facilities
Fishman, E., Fisch, M. J., Liu, Y., Barron, J. J., Nguyen, A., & Sylwestrzak, G. (2020) · JCO Oncology Practice · doi:10.1200/jop.19.00525 · Cited by 1
Adoption and use of immunotherapy in breast cancer management in Africa: barriers and prospect – a narrative review
Alani, J. M., Olaoye, D. Q., & Abdus-Salam, A. A. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001398 · Cited by 1

Authors: Newcomer, L. N., Gould, B., Page, R. D., Donelan, S. A., & Perkins, M.
Affiliations: Center for Cancer and Blood Disorders (US)
ORCID: Newcomer, Lee N.
Gould, Bruce
Page, Ray D.
Venue: Journal of Oncology Practice
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2014-09
Volume: 10
Issue: 5
Pages: 322-326
ISSN: 1554-7477 (ISSN-L)
1935-469X
DOI: 10.1200/jop.2014.001488
OpenAlex: W2110556979
Cited by: 128
References: 4
Citations by year: 2026: 5 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 12 · 2020: 8 · 2019: 14 · 2018: 11 · 2017: 14 · 2016: 28 · 2015: 20 · 2014: 8
FWCI: 57.86
Type: journal article
Language: en
Open access: closed
Locations: Journal of Oncology Practice (publishedVersion)
PubMed (publishedVersion)
Funders: American Society of Clinical Oncology
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
Health Sciences › Health Professions › General Health Professions › Healthcare cost, quality, practices
Keywords: chemotherapy costs, fee-for-service, cost reduction, quality of cancer care, breast cancer, colon cancer, lung cancer
MeSH terms: Antineoplastic Agents, Health Expenditures, Humans, Medical Oncology, Neoplasms, Physicians, Quality of Health Care, Registries, Reimbursement, Incentive, Health Care Costs, Outcome Assessment, Health Care, Fee-for-Service Plans, Quality Improvement

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Changing Physician Incentives for Affordable, Quality Cancer Care: Results of an Episode Payment Model

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks